Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  TSX VENTURE EXCHANGE  >  ImmunoPrecise Antibodies Ltd.    IPA   CA45257F2008

IMMUNOPRECISE ANTIBODIES LTD.

(IPA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on IMMUNOPRECISE ANTIBODIES LTD.
03/31/21 Q3 2021 Ergebnisveröffentlichung (geplant)
10/05/21 Q1 2022 Ergebnisveröffentlichung (geplant)
12/23/21 Erstes Halbjahr 2022 Ergebnisveröffentlichung (geplant)
03/30/22 Q3 2022 Ergebnisveröffentlichung (geplant)
Past events on IMMUNOPRECISE ANTIBODIES LTD.
01/11/21 | 12:00pm H.C. Wainwright Bioconnect Conference
12/21/20 | 02:12pm Erstes Halbjahr 2021 Ergebnisveröffentlichung
11/20/20 | 07:00pm Jahreshauptversammlung
10/01/20 | 05:00pm Gravitas Healthcare Investor Day
Upcoming sector events for IMMUNOPRECISE ANTIBODIES LTD.
01/19/21 BRIDGEBIO PHARMA, INC. : Extraordinary Shareholders Meeting - M&A Vote
01/22/21 ABBVIE INC. : FY 2020 Earnings Release (Projected)
01/22/21 | 01:00am WALVAX BIOTECHNOLOGY CO., LTD. : Extraordinary Shareholders Meeting
01/22/21 | 02:30am BETTA PHARMACEUTICALS CO., LTD. : Extraordinary Shareholders Meeting
More events
Past sector events for IMMUNOPRECISE ANTIBODIES LTD.
01/15/21 VIFOR PHARMA AG : Baader Swiss Equities Conference
01/14/21 | 02:00pm ABCAM PLC : JP Morgan Healthcare Conference
01/14/21 ROCHE HOLDING AG : Octavian Seminar
01/14/21 VIFOR PHARMA AG : Octavian Seminar
Annual publications
Annual results2018201920202021 (e)
Sales
M CAD
Released
Forecast
Spread
5,44

10,9
11,7
-6,6%
14,1
14,0
0,37%

20,4
Operating income
(EBITDA)
M CAD
Released
Forecast
Spread
-4,65

-3,90
-1,70
-129%
0,05
0,10
-48%

3,13
Operating profit
(EBIT)
M CAD
Released
Forecast
Spread




-4,55
-3,28
-39%

-4,80
Pre-Tax Profit
(EBT)
M CAD
Released
Forecast
Spread




-5,29
-4,10
-29%

-2,35
Net income
M CAD
Released
Forecast
Spread




-4,95
-4,29
-15%

-2,59
EPS
CAD
Released
Forecast
Spread
-0,55



-0,35
-0,30
-17%

-0,14
Announcement Date08/28/201808/28/201908/28/2020

Quarterly publications
Previous periodNext period
Quarterly results2019 Q32019 Q42020 Q42021 Q12021 Q22021 Q3 (e)
Sales
M CAD
Released
Forecast
Spread
2,70
2,80
-3,7%
2,64
3,40
-22%
4,15
4,09
1,3%
3,76
4,48
-16%
4,75
4,74
0,23%

5,85
Operating income
(EBITDA)
M CAD
Released
Forecast
Spread
-0,46
-0,28
-64%


0,03
0,08
-59%
0,93
0,09
940%
0,80
0,69
14%

1,05
Operating profit
(EBIT)
M CAD
Released
Forecast
Spread




-1,57
-0,29
-440%
-0,97
-0,29
-231%
-2,27
-0,38
-497%

-0,44
Pre-Tax Profit
(EBT)
M CAD
Released
Forecast
Spread




-1,48
-0,29
-412%
-0,37
-0,29
-25%
-0,41
-0,38
-6,6%

-0,44
Net income
M CAD
Released
Forecast
Spread




-0,95
-0,29
-226%
-0,55
-0,29
-87%
-0,46
-0,38
-21%

-0,44
EPS
CAD
Released
Forecast
Spread




-0,05

-0,05

-0,03
-0,02
-50%

-0,03
Announcement Date03/27/201908/28/201908/28/202009/29/202012/21/2020

Financial data source
© 2021 S&P Global Market Intelligence
© 2021 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise